Read More

中海石油化学2025年中期实现收入人民币58.50亿元 盈利人民币6.41亿元

财务摘要(人民币亿元)截至 6 月 30日止年度2025年中期2024年中期变动收入58.5060.07- 2.61%毛利8.4810.03- 15.45%税前利润8.398.99-6.67%本公司拥有人应占净利润6.416.87- 6.70%每股基本盈利 (人民币元)0.140.15- 6.67%香港,2025年8月19日 - (亚太商讯 via SeaPRwire.com) - 中海石油化学股份有限公司(「中海石油化学」或「公司」,股份编号:3983) 公布截至2025年6月30日止日止半年度未经审计之业绩。2025年上半年公司实现收入人民币5,850百万&#20803...

Read More

鲍威尔讲话可能影响市场

(SeaPRwire) -   全球投资者正密切关注美联储主席杰罗姆·鲍威尔即将在杰克逊霍尔经济研讨会上发表的讲话。这一年度盛会通常会为未来的货币政策定下基调,鉴于当前经济面临通胀担忧和市场波动,鲍威尔的讲话今年可能尤其具有影响力。 Evercore的分析师警告称,鲍威尔的讲话可能引发显著的市场反应,如果他的言论被解读为过度鹰派,市场可能会&#...

Read More

Champion REIT Announces 2025 Interim Results

- Langham Place Mall marks 20 years of excellence "Stay Local, Trend Global", becoming a brand hotspot with Chiikawa Ramen Buta’s premier overseas debut- Three Garden Road successfully concluded all 2025 expirations with high retention rate- Langham Place Office Tower unveiled “6D Wellness” concept, an innovative concept strengthening its positioning as a one-stop wellness and lifestyle hub- Lower Hibor reduced interest expenses; all 2025 debt successfully refinancedHONG KONG, Aug 19, 2025 - (ACN Newswire via SeaPRwire.com) - Champion Real Estate Investment Trust (stock code: 2778), the owner of Three Garden Road and Langham Place, announces its financial results for the six months ended 30 June 2025.Summary of financial results 1H 20251H 2024ChangeTotal Rental Income (HK$ million)1,0291,115- 7.6%Net Property Income (HK$ million)859954- 10.0%Distributable Income (HK$ million)476544- 12.6%  Distribution per unit (HK$)0.07010.0809- 13.3% 30 Jun 202531 Dec 2024ChangeGross Value of Portfolio (HK$ million)58,09860,104- 3.3%Net Asset Value per unit (HK$)6.797.16- 5.2%Gearing Ratio24.5%23.7%+ 0.8ppOverviewWhile the global economy faced headwinds from ...

Read More

Focus Graphite Announces Board Changes and Upcoming International Trade Mission with Natural Resources Canada

Susan Rohac, ICD.D, built one of Canada's largest and most active climate funds, overseeing a Pan-Canadian team of investment professionals and managed a portfolio over $1 billion in assets.Ottawa, Ontario--(ACN Newswire via SeaPRwire.com - August 18, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading Canadian graphite developer advancing high-grade projects in Québec, is pleased to announce the appointment of Mrs. Susan Rohac, ICD.D, to its Board of Directors, effective immediately. Mrs. Rohac replaces long-serving director Robin Dow, who has stepped down from the Board to focus on personal pursuits and other interests, and will continue to support a smooth transition.Susan Rohac had an extensive thirty-four (34) plus year career at the Business Development Bank of Canada ("BDC"), holding various leadership roles. Her final role was as Managing Partner of the Climate Tech venture capital fund, which she held from 2017 to May 2025. In this role, she oversaw a pan-Canadian team of investment professionals and managed a portfolio of over $1 billion in assets. This portfolio included a fully deployed $600 million fund I and a $500 ...

Read More

Australian Breakthrough by Cholrem: Cyclodextrin Therapy Reverses Heart Disease, Hailed as Greatest Advance Since Statins

BRISBANE, AUS, Aug 19, 2025 - (ACN Newswire via SeaPRwire.com) - Cholrem Pty Ltd, an Australian pharmaceutical research company, has published a landmark study in Cardiology Research and Cardiovascular Medicine, revealing that its proprietary cyclodextrin-based therapy Cavadex reverses atherosclerotic cardiovascular disease (ASCVD), the world's leading cause of death.Angiogram: Plaque Reduced Within 6 WeeksThe peer-reviewed case series demonstrates rapid symptom relief and significant regression of arterial plaque, marking a potential paradigm shift in heart disease treatment. The study followed 20 high-risk patients with advanced angina, with 18 (90%) reporting substantial symptom improvement (P0.0001) compared to expected outcomes. Objective imaging confirmed unprecedented results, including Coronary Artery Calcium (CAC) score reductions (e.g., from 591 to 521) and a 70% coronary artery blockage reduced to 27%. Cavadex, formulated with 2-hydroxypropyl-β-cyclodextrin (HPβCD), stimulates the body's natural vascular repair, offering a faster, more effective approach than existing therapies.The late Professor Laurie G. Howes, a renowned Australian cardiologist and...

Read More

吉姆·查诺斯的做空策略

(SeaPRwire) -   著名做空投资者吉姆·查诺斯(Jim Chanos)分享了他对当前市场状况的见解,强调了他在某些行业中发现的脆弱性。查诺斯尤其以对那些商业模式不可持续、估值过高的公司持看跌立场而闻名。 他最近的目标之一是快餐行业的公司Chipotle Mexican Grill (NYSE:CMG),他认为鉴于其面临的竞争压力和市场饱和度,该公司估值过高。查诺斯认为,尽管Chipotle享有强大的品&#29260...

Read More

uSMART Group Accelerates Expansion with 12 New Branches

HONG KONG, Aug 19, 2025 - (ACN Newswire via SeaPRwire.com) - uSMART Securities, a strategic investment of Chow Tai Fook (Holding) Limited, is pleased to announce the official launch of its new branches at Hong Kong’s Lok Ma Chau MTR Station and West Kowloon High-Speed Rail Station, strategically positioned to serve cross-border clients and passengers. A grand opening ceremony was held at the West Kowloon branch, attended by prominent financial professionals.At the event, Mr. Neo Lee, Executive Director of uSMART Securities, stated: "To provide more accessible financial services, uSMART Group plans to open 12 service centers across Hong Kong and Singapore this year, covering key districts such as Tsim Sha Tsui, Causeway Bay, Tsuen Wan, Sheung Shui, and Sheung Wan. This expansion will enhance our regional service network and bring us closer to our local clients."“As a No.1 Hong Kong Funded Fintech Brokerage^ with over 800,000 users globally, uSMART Securities is committed to elevating the investment experience. Our new branches offer comprehensive services, including investment consultations, account opening assistance, and personalized support for seniors and beginners t...

Read More

中国生物制药(1177.HK)公布2025中期业绩

重点成果- 期内,集团共有2个创新产品获中国国家药品监督管理局(「NMPA」)批准上市,分别为普坦宁(美洛昔康注射液(II))和安启新(注射用重组人凝血因子VIIa N01)。- 2025年上半年,集团创新产品收入达到人民币78亿元,同比增长27.2%。除创新产品外,集团还有5个仿制药获NMPA批准上市,整体仿制药收入在2025年上半年保持正增长。- 截至2025年6月30日,集团共有37个肿瘤领域、7个肝病╱代谢领域、13个呼吸系统领域、和6个外科╱镇痛领域的创新候选药物处于临床申请及以上开发阶段。其中,2个肿瘤领域、1个外科╱镇痛领域产品处在上市申请阶段;11个肿瘤领域、1个肝病╱代谢领域、3个呼吸系统领域、1个外科╱镇痛领域的创新候选药物处于临床III期;另有13个肿瘤领域、6个肝病╱代谢领域、12个呼吸系统领域、6个外科╱镇痛领域的生物类似药或仿制药候选药物处于临床申请及以上开发阶段。- 福可维(盐酸安罗替尼胶囊)是一种新型小分子多靶点酪氨酸激酶抑制剂,目前已获批9个适应症,另有3个适应症处于上市申请阶段。此外,安罗替尼还有多项新适应症处于III期临床研究阶段,包括一线非鳞状非小细胞肺癌、一线胰腺癌等,预计将在未来两年逐步递交上市申请。- 2023-2024年,集团共有5款肿瘤领域的国家1类创新药获批上市,分别为:亿立舒(艾贝格司亭α注射液)、安得卫(贝莫苏拜单抗注射液)、安柏尼(富马酸安奈克替尼胶囊)、安洛晴(枸橼酸依奉阿克胶囊)和安方宁(格索雷塞片);以及4款肿瘤领域的生物类似药获批上市,分别为:安倍斯(贝伐珠单抗注射液)、得利妥(利妥昔单抗注射液)、赛妥(注射用曲妥珠单抗)和帕乐坦(帕妥珠单抗注射液)。该等产品在2025年上半年快速放量,成为集团收入增长的重要贡献品种。- 拉尼兰诺(泛PPAR激动剂)是一种口服小分子药物,用于治疗代谢功能障碍相关脂肪性肝炎(MASH),目前正在全球开展III期临床试验,已完成全部受试者入组。2023年7月,拉尼兰诺被药品评审中心「CDE」纳入突破性治疗药物程序。拉尼兰诺是中国第一个进入临床III期的MASH口服药物,有望填补中国市场空白。- 天晴速畅(吸入用布地奈德混悬液)是中国首款获批上市的布地奈德雾化剂型仿制药,打破了国内市场长期被原研垄断的局面,为国内气道慢性炎症患者带来了兼具有效性、安全性与经济性的高端制剂产品。该产品已被纳入集采范围,集团及时采取了一系列主动管理措施,包括管道下沉、拓展市场覆盖和集采外市场的二次开发。- 泽普思╱得百安(氟比洛芬凝胶贴膏)是中国首个获批上市的国产凝胶贴膏,连续多年蝉联外用镇痛市场份额第一位。集团聚焦高潜力地区开发,深入拓展市场覆盖,并逐步扩大产能以满足市场的旺盛需求,推动泽普思/得百安销售额持续快速增长。集团开发的第二代氟比洛芬贴剂预计将在一年内获批上市。通过剂型升级,...

Read More

下一个像 Nvidia 一样势不可挡的股票

(SeaPRwire) -   在科技投资领域,Nvidia(NASDAQ:NVDA)是成功的典范。它从半导体行业的一家普通公司成长为人工智能和图形处理领域的巨头,这一历程有据可查。投资者现在正急切地寻找下一家有望复制Nvidia迅猛增长的公司。一家专注于尖端AI解决方案的新兴科技公司正受到关注。 这家我们称之为“Tech Innovator”的公司,正凭借其旨在优化数据处理效率的革命性AI算法掀&#3...

Read More

盈立集团积极扩张 开设12间分行 扎根香港新加坡 服务全球投资者

香港,2025年8月19日 - (亚太商讯 via SeaPRwire.com) - 由周大福控股战略入股的uSMART盈立证券欣然宣布香港落马洲港铁站,西九龙高铁站分行已正式投入服务,涵盖陆路出入境和高铁枢纽客戶群。为庆祝这一里程碑,盈立证券今日在西九龙分行举行简单而隆重的开幕仪式,并邀得不少财经界精英出席,令活动生色不少。开幕礼上,盈立证券执行董事李建翰先生(Neo Lee&#...

Read More

Palo Alto 的战略性 CyberArk 交易

(SeaPRwire) -   Palo Alto Networks 最近宣布收购 CyberArk,此举彰显了该公司在网络安全行业的强大地位。这一战略性决策符合 Palo Alto 增强其网络安全产品并扩大市场份额的愿景。 Palo Alto Networks (NASDAQ:PANW) 在财务业绩上持续表现强劲,近期季度报告的收益超出预期。收购身份安全领域的领导者 CyberArk 预计将增强 Palo Alto 提供全面安全解决方案的能力。 该交易是在 Palo Alto 令人印象深刻的财务业绩公布后&...

Read More

Team Mitsubishi Ralliart Triumphs at Asia Cross Country Rally 2025 with Chayapon Yotha’s Overall Victory and Team Award

TOKYO, August 18, 2025 - (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Team Mitsubishi Ralliart, which receives technical support from the company, has won first place in the Asia Cross Country Rally (AXCR) 2025, held in Thailand from August 8 to 16. The team competed with the Triton1 pickup truck (T1 specification, or modified cross-country vehicle), covering a total distance of 2,316.32 kilometers (km), including 1,002.95 km of Special Stages (SS)2.Team Mitsubishi RalliartIn the overall standings, Chayapon Yotha secured first place with a total time of 16 hours, 15 minutes and 12 seconds; Katsuhiko Taguchi finished in fifth place; and Kazuto Koide placed 22nd overall. The team also earned the Team Award – given to teams with three or more finishers based on the combined time of their top two vehicles – for the second time, and the first in two years.This year’s AXCR kicked off with a ceremonial start at Walking Street, a well-known tourist spot in Pattaya, Thailand. The rally officially began the following day with Leg 1, traveling roughly 360 km northeast from Pattaya to Prachin Buri in eastern Thailand. This leg f...

Read More

UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System

Tokyo, Japan, August 18, 2025 - (JCN Newswire via SeaPRwire.com) — NEC Corporation (NEC; TSE: 6701) today announced the signing of a Memorandum of Understanding (MOU) with the United Nations Population Fund (UNFPA) (*1), which promotes activities to protect the health and rights of women and girls, to collaborate on the development of a beneficiary information management system.Both parties will promote digitization in the management of beneficiary information supported by the UNFPA and implement privacy-conscious operations, thereby contributing to the provision of rapid, safe, and secure support. This system will be implemented in Nigeria and Madagascar by the end of 2025, supported by the Ministry of Foreign Affairs in Japan and aiming to build on this partnership in other parts of the world.NEC Chief of Staff for the CDO and Head of the Marketing & Alliance Promotion Department, Mayuko Tatewaki (left), UNFPA Director, Division for External Relations, Ian McFarlane (center left), UNFPA Director, Information Technology Solution Office, Soren Thomassen (center right), and UNFPA Chief, Representation office in Tokyo, Japan, Eiko Narita (right)The UNFPA is the United Nations sex...

Read More

Hitachi High-Tech and NOF Metal Coatings use materials informatics to improve the efficiency and sophistication of research and development work

TOKYO, August 19th, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech ("Hitachi High-Tech") is providing its MI Solutions using Materials Informatics ("MI") to the NOF Metal Coatings Group ("NOF"). We are working together to explore ways to improve the efficiency and sophistication of research and development operations. This has led to a more than 50% reduction in costs related to the number of experiments and time required, as well as to the discovery of new ideas that were difficult to achieve by our own know-how alone, thereby contributing to improved efficiency and sophistication in our research and development work.Background and OverviewNOF's high-performance thin layer coating technology is used to improve the durability and functionality of metals. NOF mainly develops and manufactures rust-proof materials that protect metals from rust, and provides them to a wide range of industries including the automotive and aviation industries, both in Japan and overseas. In recent years, there have been more and more demands regarding new value and product development, such as product safety and consideration for the environment. In addition, we have previously relied on the...

Read More

CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers

SHENZHEN, CHINA, Aug 19, 2025 - (ACN Newswire via SeaPRwire.com) - On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. During the Reporting Period, the Company recorded revenue of approximately RMB4.00 billion, representing a year-on-year increase of 10.8%. In the case that all medicines were directly sold by the Company, revenue would be approximately RMB4.67 billion, up 8.9% year-on-year. Net profit was approximately RMB0.93 billion, representing an increase of 3.1% year-on-year.The results reflect that CMS has emerged from the shadow of National Volume-based Procurement (“National VBP”), and its performance is expected to return to a sustainable growth trajectory. Revenue from the Company’s key non-National VBP exclusive/branded products and innovative products (in the case that all medicines were directly sold by the Company) reached approximately RMB2.90 billion, up 20.6% year-...

Read More

俄罗斯梅德韦杰夫称,欧洲“自愿联盟”在泽连斯基会晤后未能智胜特朗普

(SeaPRwire) -   俄罗斯前总统德米特里·梅德韦杰夫周一早些时候嘲讽欧洲领导人,指责他们"未能胜过"美国总统唐纳德·特朗普。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、&#2...

Read More

Focus Graphite Announces Board Changes and Upcoming International Trade Mission with Natural Resources Canada

Susan Rohac, ICD.D, built one of Canada's largest and most active climate funds, overseeing a Pan-Canadian team of investment professionals and managed a portfolio over $1 billion in assets.Ottawa, Ontario--(ACN Newswire via SeaPRwire.com - August 18, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading Canadian graphite developer advancing high-grade projects in Québec, is pleased to announce the appointment of Mrs. Susan Rohac, ICD.D, to its Board of Directors, effective immediately. Mrs. Rohac replaces long-serving director Robin Dow, who has stepped down from the Board to focus on personal pursuits and other interests, and will continue to support a smooth transition.Susan Rohac had an extensive thirty-four (34) plus year career at the Business Development Bank of Canada ("BDC"), holding various leadership roles. Her final role was as Managing Partner of the Climate Tech venture capital fund, which she held from 2017 to May 2025. In this role, she oversaw a pan-Canadian team of investment professionals and managed a portfolio of over $1 billion in assets. This portfolio included a fully deployed $600 million fund I and ...

Read More

CENTRESTAGE 10th anniversary set to dazzle in September

HONG KONG, Aug 18, 2025 - (ACN Newswire via SeaPRwire.com) - CENTRESTAGE – the annual gala event for the Asian fashion industry – takes place from 3 to 6 September 2025 at the Hong Kong Convention and Exhibition Centre (HKCEC). Unveiling a grand celebration of style for its 10th anniversary edition, this year’s CENTRESTAGE sees a record participation of some 260 brands from 24 countries and regions. The programme features more than 40 events, including around 30 fashion shows and parades – another record for the event. Organised by the Hong Kong Trade Development Council (HKTDC) and sponsored by the Cultural and Creative Industries Development Agency (CCIDA) of the Government of the Hong Kong Special Administrative Region (HKSAR), the four-day showcase is open to industry professionals and the public free of charge, welcoming visitors from Hong Kong, Mainland China and overseas to experience the charm and creativity of Asia’s fashion capital.Sophia Chong, Deputy Executive Director of the HKTDC, said: “Over the past decade, CENTRESTAGE has become the perfect meeting point for fashion brands and designers from across the globe, and Asia i...

Read More

康哲药业(867.HK,8A8.SG)上半年营收净利双升 战略转型跑出增长新动能

深圳,2025年8月19日 - (亚太商讯 via SeaPRwire.com) - 8月18日,康哲药业发布2025年中期业绩,公司营收和利润同比均实现增长,战略转型成效初显。报告期内,公司实现营业收入约40.0亿元(人民币,下同),同比增长10.8%。若全按药品销售收入计算则营收约46.7亿元,同比增长8.9%。实现净利润约9.3亿元,同比增长3.1%。具体来看,康哲药业已走出国采阴霾,业绩将回归持续上升...

特朗普敦促泽连斯基在白宫会晤前放弃收复克里米亚和加入北约

(SeaPRwire) - 总统 已告知乌克兰总统 放弃乌克兰收复克里米亚或加入NATO的想法。 “乌克兰总统泽连斯基可以几乎立即结束与俄罗斯的战争,如果他愿意的话,或者他可以继续战斗,”特朗普周日晚间通过Truth Social表示,称克里米亚“无法收回”,乌克兰也“无法加入NATO”。 特朗普目前专注于达成一项和平协议而非停火协议以结束俄乌战争(该战争是在 触发的),他在周一与泽连斯基和主要欧洲领导人计划在白宫举行会议之前分享了这一建议。 乌克兰寻求加入NATO的努力由来已久,这是俄罗斯的一个争议点。在六月初的年度会议上,匈牙利总理维克多·欧尔班(俄罗斯总统弗拉基米尔·普京的盟友)表示:“NATO在乌克兰没有业务。乌克兰不是NATO成员,俄罗斯也不是,我的职责是保持现状。” NATO在此事上一直坚持其立场。 “乌克兰不是NATO成员。乌克兰是NATO伙伴国,这意味着它与NATO密切合作,但不受联盟创始条约中的安全保障覆盖,” 他特别指出,“NATO以最强烈的措辞谴责俄罗斯对乌克兰发动残酷和无端侵略战争。” 与此同时,克里米亚自2014年以来一直处于,当时 控制了该领土。俄罗斯最初否认直接参与占领。 特朗普周日晚间的言论是在他周五前往阿拉斯加参加他所称的“”普京峰会之后发表的。 此次峰会是特朗普和普京首次面对面会晤,旨在促进关于潜在停火路径的讨论,但它比预期提前结束,并且未达成任何协议。特朗普和普京之后只简短地与记者交谈,都没有回答任何问题。 尽管此次活动虎头蛇尾,但特朗普称这次会面“极其富有成效”,此后他猛烈抨击他所谓的“假新闻”,坚称他与普京进行了一次“”会谈。 阐述其理由,特朗普说:“所有人都认为,结束俄罗斯与乌克兰之间这场可怕战争的最佳方式是直接达成和平协议,这将结束战争,而不是仅仅停火协议,后者常常无法维持。” 特朗普周日深夜的评论,以及他公开向泽连斯基就其如何结束战争的愿景所作的指示,与他此前的言论一致。 在四月份,当被问及乌克兰的和平之路时,特朗普表示克里米亚(他一再称其为巴拉克·奥巴马在俄罗斯吞并克里米亚时“给予”的)将继续由俄罗斯控制。 “他们[乌克兰]能把它拿回来吗?他们有他们的俄罗斯人。他们在我们谈论的任何时期之前很久,已经把潜艇放在那里很多年了。克里米亚的人口大多讲俄语,”这位美国总统说。 在同一次采访中,特朗普还表示他看不到乌克兰在NATO的未来。 “我认为他们永远无法加入NATO。我认为从第一天起,那一直就是,我认为那就是战争开始的原因,当他们开始谈论加入NATO时,”他坚持道。 此外,特朗普此前也曾表示,俄乌战争的持久停火可能只能通过“为了双方的利益”交换领土来实现。泽连斯基及其欧洲盟友强烈谴责这一想法,泽连斯基表示乌克兰不会“将他们的土地赠送给占领者”。 泽连斯基曾与特朗普在 期间有过著名的冲突,这一次他将在 返回白宫时得到...